The report covers the analysis of global as well as regional markets of Drug Discovery Technologies. Moreover, the report gives insights into the factors that affect the global as well as regional performance of the market in the short run and in the long run.
The global artificial intelligence (AI) in drug discovery market size is expected to reach USD 4.05 billion by 2028 according to a new study by Polaris Market Research.
Major players in the artificial intelligence (AI) in drug discovery market are IBM Corporation, Microsoft, Atomwise Inc., Deep Genomics...... @ @ https://bit.ly/3D4dtix
The global drug discovery informatics market size is expected to reach USD 5.62 billion by 2028 according to a new study by Polaris Market Research. The report “Drug Discovery Informatics Market Share, Size, Trends, Industry Analysis Report, By Workflow (Discovery Informatics, Development Informatics); By Mode (Outsourced, In-house); By Services (Sequence Analysis Platforms, Molecular Modeling, Docking, Clinical Trial Data Management, Others); By Regions; Segment Forecast, 2021 – 2028”
The global artificial intelligence (AI) in drug discovery market is expected to grow from $0.36 billion in 2020 to $0.47 billion in 2021 at a compound annual growth rate (CAGR) of 30.6%.
Global drug discovery informatics market was valued approximately US$ 2.0 Bn in 2016 and is anticipated to register CAGR of over 17.0% from 2017 to 2025 to reach value of approximately US$ 7.8 Bn by 2025.
Major players in the artificial intelligence (AI) in drug discovery market are IBM Corporation, Microsoft, Atomwise Inc., Deep Genomics, Cloud Pharmaceuticals... @@ https://bit.ly/3y2JLrb
Drug Discovery Informatics Market size was USD 1.6 billion in 2015 and is anticipated to reach around USD 6.5 billion by 2023. Get more details @ https://goo.gl/UgKpgf
Big Market Research “Global Drug Discovery Informatics Market 2022” Size, Share, Industry Trends, Demand, Insights, Analysis, Research, Report, Opportunities, Company Profiles, Forecast
The global market for RNAi drug delivery technologies reached nearly $9.3 billion in 2012 and nearly $11.7 billion in 2013. This market is expected to grow to $38.8 billion in 2018, with a compound annual growth rate(CAGR) of 27.2% from 2013 to 2018.
Epilepsy is a brain disorder characterized by spontaneously occurring and recurrent seizures. The market is heavily driven by the sales of antiepileptic drugs (AEDs) targeted at seizure reduction. The AED market is currently dominated by UCB’s Keppra and GlaxoSmithKline’s Lamictal. Although both drugs have experienced significant generic erosion, they form the mainstay of epilepsy treatment in the nine markets and will continue to have significant market share during the forecast period. See Full Report @ bit.ly/1vM6jVN
Biomarker technology is evidencing increased application from key segments such as disease diagnosis, drug development and formulation, diagnosis for exposure of certain harmful chemical and prognostic treatments. See Full Report @ http://bit.ly/1zB1l1W
The global CRISPR Technology Market is projected to reach USD 3.94 billion by 2027, according to a recent report by Emergen Research. Certain factors that are driving the market growth include increasing government and personal funding, rising demand and adoption of CRISPR, and technological advancements.
Looking forward, the transfection technologies market value is projected to reach a strong growth during the forecast period (2021-2026). More info:- https://www.imarcgroup.com/transfection-technologies-market
Major players in the 3D cell culture technologies market are Nano3D Biosciences Corning Inc., Merck & Co., 3D Biotek LLC, 3D Biomatrix and Thermo Fisher Scientific.... @ https://bit.ly/3sXnUi9
The major players in the 3D cell culture technologies market are Nano3D Biosciences Corning Inc., Merck & Co., 3D Biotek LLC, 3D Biomatrix and Thermo Fisher Scientific.....@ @ https://bit.ly/3sXnUi9
Avail more information from Sample Brochure of report @ http://bit.ly/2dlXJ2P The study covers and analyses “Global Mammalian Market”. Bringing out the complete key insights of the industry, the report aims to provide an opportunity for players to understand the latest trends, current market scenario, government initiative and technologies related to the market. In addition, it will help the venture capitalist in understanding the companies better and take informed decisions. Read analysis @ http://bit.ly/2cYaYDP
Data Mining, and Knowledge Discovery: An Introduction Gregory Piatetsky-Shapiro Course Outline Machine Learning input, representation, decision trees Weka machine ...
The report provides drug profiles which include product description, MOA, technology, licensors & collaborators, development partner and detailed chemical information.
The market is driven by factors, such as technological advancements and innovations, increasing compliance for drug discovery processes, and high demand for organ and tissue transplantation.
Analyze Future: Leukemia Treatment Drugs Markets in China To Get More Details @ http://www.analyzefuture.com/leukemia-treatment-drugs-in-china-market China's demand for Leukemia Treatment Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2003, 2008 and 2013) and long-term forecasts through 2018 and 2023 are presented. Major producers in China are profiled.
Download Sample Brochure @ http://bit.ly/2cUzvLT Cardiovascular Inflammation-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturers across the globe. Read Analysis @ http://bit.ly/2dxrN8n
Download Sample Brochure @ http://bit.ly/2dEhRvj DelveInsight’s, “ Xerostomia-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Xerostomia. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Read Analysis @ http://bit.ly/2dwYulS
JSB Market Research promotes the latest marketing research reports on Cell Analysis Market by Instruments. The report gives the information about the the global cell analysis market is a technology-driven market and is marked by the Threat of Obsolescence, wherein technologies as well as their adoption by end users changes very rapidly.
The global central nervous system drugs market was valued at around $71 billion in 2017. North America was the largest region in the central nervous system drugs market in 2017, accounting for nearly 40% market share. Read Report https://www.thebusinessresearchcompany.com/report/central-nervous-system-drugs-global-market-report-2018
Aptamers is an emerging market, widely considered as a rival or substitute to antibodies in the scientific industry. It is poised to grow rapidly in various application areas, including therapeutics and diagnostics. The global aptamers market is valued at $287 million in 2013 and is expected to reach $2.1 billion by 2018. Aptamers existed in parallel with antibodies for two decades, but its market potential was not utilized, even to a fraction of antibodies. However, the achievement of Macugen has given a boost to the aptamer field. The list of promising aptamers in the clinical trials pipeline estimates that these synthetic chemical antibodies will soon surpass monoclonal antibodies in therapeutics, diagnosis, and imaging. With technological merits over antibodies, the aptamers market is poised to grow at par with antibodies in the next 10-15 years.
Goldstein Research analyst forecast the Metabolomics market size is set to reach USD 2.1 billion by 2024, at a CAGR of 11.3% over the forecast years. With increasing importance being placed on health and safety related aspects of food, metabolomics can potentially be a valuable tool to monitor and improve the quality of what we consume.
JSB Market Research published latest report titled "Global and USA Cancer Biomarker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis)" Browse complete report @ http://goo.gl/CYCwde
The report " Protein Engineering Market by Technology (Rational Protein Design, Irrational Protein Design), Product (Instrument, Services), Protein Type (Monoclonal Antibodies, Interferon, Growth Hormone), End User (Academics Institutes, CROs) - Global Forecast to 2020 ”, The global protein engineering market is poised to reach $1,463.0 million by 2020 from $610.3 million in 2014, at a CAGR of 15.7% from 2015 to 2020.
The new market research report, ‘Global Stem Cell and Advanced Technologies Market’ (2009 – 2014)’, published by MarketsandMarkets (www.marketsandmarkets.com) analyzes the major trends in the global stem cell market. It identifies and analyzes the main market drivers, restraints, and opportunities for the various products, services, technologies, and applications submarkets in different geographic regions
Get more information about the market: http://bit.ly/2ywjaVx Generic drugs are considered as bioequivalent of branded drugs as they are similar in terms of quality, strength, dosage and intended use. They require low capital investment as they only incur the manufacturing cost without the expenditure on drug discovery, drug development, advertising, distribution of free samples, etc. Want more information about this market? Request a free report sample: https://www.imarcgroup.com/request?type=report&id=549&flag=B Contact Us IMARC Group USA: +1-631-791-1145 Email: sales@imarcgroup.com Website: https://www.imarcgroup.com Follow us on twitter: @imarcglobal
The report covers the global elastomeric coating market and also divides it on the basis of type, applications, and region. The market data for these elastomeric coating types are given with respect to volume (kilo tons) and value ($million). See Full Report: http://bit.ly/1KvXpUy
The rising demand for advanced drugs is likely to create lucrative growth opportunities for the global “veterinary drugs market”, finds Fortune Business Insights in their new study
The metabolomics market is projected to reach USD 2.2billionin the forecasted period. North America contributed up to 45% of market share making it a market leader in metabolomics market.
The "Protein Engineering Market by Technology (Rational Protein Design, Irrational Protein Design), Product (Instrument, Services), Protein Type (Monoclonal Antibodies, Interferon, Growth Hormone), End User (Academics Institutes, CROs) - Global Forecast to 2020", report provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the Protein Engineering market along with the estimates and forecasts of the revenue and market share analysis.
Drug Discovery and Development Process of Anti-diabetic Plants Dr. Basavaraj K. Nanjwade M. Pharm., Ph. D Professor of Pharmaceutics KLE University College of Pharmacy
Bharat Book Presents"Cell-Based Assays: World Market Prospects 2013-2023"Cellular assays form an important part of drug discovery and testing. With our report, you assess products, services, technologies (platforms) and companies in that fast-growing field.
Global Cancer Biomarkers Market By Type (genetic biomarkers, protein biomarkers, other cancer biomarkers) cancer type (breast cancer, lung cancer, prostate cancer, colorectal cancer , blood cancer, melanoma , ovarian cancer, liver cancer, stomach cancer, other cancer types ), technology ( imaging technologies, omic technologies (proteomics, genomics, other omic technologies), cytogenetics-based tests, immunoassays), applications (drug discovery and development, personalized medicine, diagnostics, others)
The advancing of high throughput data is accelerating the shift towards automated liquid handling systems market. Also, various drug discovery applications are opening up new vistas for liquid handling companies across the globe. The global Liquid Handling System Market is $2.9 billion in 2017 and is estimated to grow at CAGR 2.4% during 2018-2023. North America hold the largest market share with 41% and is growing at a CAGR of 4.4%. Growth wise by instruments automated pipetting systems have the highest share with $817M in 2017 and is estimated to grow at a CAGR of 2.0% during 2017-2023.
According to Data Bridge Market Research new Market report “Global Anatomic Pathology Market, By Product & Service {Instruments (Tissue Processing Systems, Microtome), Consumables (Reagent & Antibodies), Histopathology, Cytopathology}; Application (Disease Diagnosis, Drug Discovery & Development); Geography (North America, Europe, Asia-Pacific, Europe, South America, Middle East and Africa) – Industry Trends and Forecast to 2024”, the global anatomic pathology market accounted to USD 16.5 billion in 2016 at a CAGR of 6.3% during the forecast period of 2017 to 2024.
Ion chromatography mass spectrometry market offers wide applications in food, pharmaceutical, biotechnology industries helps in process validation and clinical testing of protein identification and quantitative analysis of drugs, pharmacokinetics, proteomics, biomarker discovery, food nutritional composition testing, environment testing and others. Wide application and demand of mass spectrometry in drug discovery have augmented the market growth.
[171 Slides Report] Aptamers Market categories the global market By Applications - Biosensors , Biomarker Discovery , Therapeutics , Diagnostics, Drug Discovery, by Technology Trends & by Geography
The latest report published by Persistence Market Research titled “Global Market Study on Precision Medicine: Drug Discovery Technology Segment Estimated to Witness 0.1% Decline in Market Share Between 2016 and 2024“. projects some of the crucial aspects of the global precision medicine market after an in-depth research. The report assures that the market will grow manifold and it will register a 14.7% CAGR between 2016 and 2024.
The latest report published by Persistence Market Research titled “Global Market Study on Precision Medicine: Drug Discovery Technology Segment Estimated to Witness 0.1% Decline in Market Share Between 2016 and 2024“. projects some of the crucial aspects of the global precision medicine market after an in-depth research. The report assures that the market will grow manifold and it will register a 14.7% CAGR between 2016 and 2024.